Monks B - Search Results

1

Molecular characterization of the interaction between sialylated Neisseria gonorrhoeae and factor H.

Shaughnessy J, Ram S, Bhattacharjee A, Pedrosa J, Tran C, Horvath G, Monks B, Visintin A, Jokiranta TS, Rice PA. Shaughnessy J, et al. Among authors: monks b. J Biol Chem. 2011 Jun 24;286(25):22235-42. doi: 10.1074/jbc.M111.225516. Epub 2011 Apr 29. J Biol Chem. 2011. PMID: 21531728 Free PMC article.

2

Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion.

Ngampasutadol J, Ram S, Gulati S, Agarwal S, Li C, Visintin A, Monks B, Madico G, Rice PA. Ngampasutadol J, et al. Among authors: monks b. J Immunol. 2008 Mar 1;180(5):3426-35. doi: 10.4049/jimmunol.180.5.3426. J Immunol. 2008. PMID: 18292569

3

A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.

Shaughnessy J, Gulati S, Agarwal S, Unemo M, Ohnishi M, Su XH, Monks BG, Visintin A, Madico G, Lewis LA, Golenbock DT, Reed GW, Rice PA, Ram S. Shaughnessy J, et al. Among authors: monks bg. J Immunol. 2016 Feb 15;196(4):1732-40. doi: 10.4049/jimmunol.1500292. Epub 2016 Jan 15. J Immunol. 2016. PMID: 26773149 Free PMC article.

4

Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction.

Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT, Espevik T. Latz E, et al. J Biol Chem. 2002 Dec 6;277(49):47834-43. doi: 10.1074/jbc.M207873200. Epub 2002 Sep 24. J Biol Chem. 2002. PMID: 12324469 Free article.

5

Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction.

Visintin A, Latz E, Monks BG, Espevik T, Golenbock DT. Visintin A, et al. J Biol Chem. 2003 Nov 28;278(48):48313-20. doi: 10.1074/jbc.M306802200. Epub 2003 Sep 5. J Biol Chem. 2003. PMID: 12960171 Free article.

6

Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae.

Ram S, Cullinane M, Blom AM, Gulati S, McQuillen DP, Monks BG, O'Connell C, Boden R, Elkins C, Pangburn MK, Dahlbäck B, Rice PA. Ram S, et al. Among authors: monks bg. J Exp Med. 2001 Feb 5;193(3):281-95. doi: 10.1084/jem.193.3.281. J Exp Med. 2001. PMID: 11157049 Free PMC article.

7

Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2.

Visintin A, Halmen KA, Latz E, Monks BG, Golenbock DT. Visintin A, et al. J Immunol. 2005 Nov 15;175(10):6465-72. doi: 10.4049/jimmunol.175.10.6465. J Immunol. 2005. PMID: 16272300

8

C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae.

Ram S, Cullinane M, Blom AM, Gulati S, McQuillen DP, Boden R, Monks BG, O'Connell C, Elkins C, Pangburn MK, Dahlbäck B, Rice PA. Ram S, et al. Among authors: monks bg. Int Immunopharmacol. 2001 Mar;1(3):423-32. doi: 10.1016/s1567-5769(00)00037-0. Int Immunopharmacol. 2001. PMID: 11367527 Review.

9

MD-2.

Visintin A, Iliev DB, Monks BG, Halmen KA, Golenbock DT. Visintin A, et al. Among authors: monks bg. Immunobiology. 2006;211(6-8):437-47. doi: 10.1016/j.imbio.2006.05.010. Epub 2006 Jul 18. Immunobiology. 2006. PMID: 16920483 Review.

10

MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4).

Visintin A, Halmen KA, Khan N, Monks BG, Golenbock DT, Lien E. Visintin A, et al. J Leukoc Biol. 2006 Dec;80(6):1584-92. doi: 10.1189/jlb.0606388. Epub 2006 Aug 31. J Leukoc Biol. 2006. PMID: 16946018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page